These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10336629)

  • 1. Roles of key functional groups in omega-conotoxin GVIA synthesis, structure and functional assay of selected peptide analogues.
    Flinn JP; Pallaghy PK; Lew MJ; Murphy R; Angus JA; Norton RS
    Eur J Biochem; 1999 Jun; 262(2):447-55. PubMed ID: 10336629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-function relationships of omega-conotoxin GVIA. Synthesis, structure, calcium channel binding, and functional assay of alanine-substituted analogues.
    Lew MJ; Flinn JP; Pallaghy PK; Murphy R; Whorlow SL; Wright CE; Norton RS; Angus JA
    J Biol Chem; 1997 May; 272(18):12014-23. PubMed ID: 9115267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of disulfide bridges in the folding, structure and biological activity of omega-conotoxin GVIA.
    Flinn JP; Pallaghy PK; Lew MJ; Murphy R; Angus JA; Norton RS
    Biochim Biophys Acta; 1999 Sep; 1434(1):177-90. PubMed ID: 10556572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyr13 is essential for the activity of omega-conotoxin MVIIA and GVIA, specific N-type calcium channel blockers.
    Kim JI; Takahashi M; Ohtake A; Wakamiya A; Sato K
    Biochem Biophys Res Commun; 1995 Jan; 206(2):449-54. PubMed ID: 7826361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residue Gly1326 of the N-type calcium channel alpha 1B subunit controls reversibility of omega-conotoxin GVIA and MVIIA block.
    Feng ZP; Hamid J; Doering C; Bosey GM; Snutch TP; Zamponi GW
    J Biol Chem; 2001 May; 276(19):15728-35. PubMed ID: 11279062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional structure in solution of the calcium channel blocker omega-conotoxin MVIIA.
    Kohno T; Kim JI; Kobayashi K; Kodera Y; Maeda T; Sato K
    Biochemistry; 1995 Aug; 34(32):10256-65. PubMed ID: 7640281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional structure in solution of the calcium channel blocker omega-conotoxin.
    Pallaghy PK; Duggan BM; Pennington MW; Norton RS
    J Mol Biol; 1993 Nov; 234(2):405-20. PubMed ID: 8230223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular dichroism spectra of calcium channel antagonist omega-conotoxins.
    Kim JI; Ohtake A; Sato K
    Biochem Biophys Res Commun; 1997 Jan; 230(1):133-5. PubMed ID: 9020029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyl group of Tyr13 is essential for the activity of omega-conotoxin GVIA, a peptide toxin for N-type calcium channel.
    Kim JI; Takahashi M; Ogura A; Kohno T; Kudo Y; Sato K
    J Biol Chem; 1994 Sep; 269(39):23876-8. PubMed ID: 7929033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of N-, P- and Q-type neuronal calcium channel antagonists on mammalian peripheral neurotransmission.
    Wright CE; Angus JA
    Br J Pharmacol; 1996 Sep; 119(1):49-56. PubMed ID: 8872356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclic contryphan motif CPxXPXC, a robust scaffold potentially useful as an omega-conotoxin mimic.
    Pallaghy PK; Norton RS
    Biopolymers; 2000 Sep; 54(3):173-9. PubMed ID: 10861378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of omega-conotoxin MVIIA using 2D NMR spectroscopy.
    Basus VJ; Nadasdi L; Ramachandran J; Miljanich GP
    FEBS Lett; 1995 Aug; 370(3):163-9. PubMed ID: 7656969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure of the calcium channel antagonist omega-conotoxin GVIA.
    Skalicky JJ; Metzler WJ; Ciesla DJ; Galdes A; Pardi A
    Protein Sci; 1993 Oct; 2(10):1591-603. PubMed ID: 8251934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional solution structure of omega-conotoxin TxVII, an L-type calcium channel blocker.
    Kobayashi K; Sasaki T; Sato K; Kohno T
    Biochemistry; 2000 Dec; 39(48):14761-7. PubMed ID: 11101291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refined solution structure of omega-conotoxin GVIA: implications for calcium channel binding.
    Pallaghy PK; Norton RS
    J Pept Res; 1999 Mar; 53(3):343-51. PubMed ID: 10231724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological characterization of a series of analogues of omega-conotoxin GVIA.
    Flinn JP; Murphy R; Boublik JH; Lew MJ; Wright CE; Angus JA
    J Pept Sci; 1995; 1(6):379-84. PubMed ID: 9223017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of basic residues for the binding of omega-conotoxin GVIA to N-type calcium channels.
    Sato K; Park NG; Kohno T; Maeda T; Kim JI; Kato R; Takahashi M
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1292-6. PubMed ID: 8394704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of individual disulfide bonds in the stability and folding of an omega-conotoxin.
    Price-Carter M; Hull MS; Goldenberg DP
    Biochemistry; 1998 Jul; 37(27):9851-61. PubMed ID: 9657699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence that tetraethylammonium-sensitive, iberiotoxin-insensitive K+ channels function as a negative feedback element for sympathetic neurotransmission by suppressing omega-conotoxin-GVIA-insensitive Ca2+ channels in the relaxation of rabbit facial vein.
    Tanaka Y; Akutsu A; Tanaka H; Horinouchi T; Tsuru H; Koike K; Shigenobu K
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):35-42. PubMed ID: 12616339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solution structure determination by two-dimensional 1H NMR of omega-conotoxin MVIID, a calcium channel blocker peptide.
    Civera C; Vázquez A; Sevilla JM; Bruix M; Gago F; García AG; Sevilla P
    Biochem Biophys Res Commun; 1999 Jan; 254(1):32-5. PubMed ID: 9920728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.